This content is from: Premium
Two Viking Portfolio Companies to Go Public This Week
Three biopharmaceutical companies with hedge fund investors are poised for their public market debuts over the next few days.
Biopharma IPO mania continues. At least three biopharmaceutical companies with hedge fund investors are planning to go public this week, two of which count Viking Global Investors as a significant investor.Many investors — and the financial media — are fixated on the initial public offerings (IPOs) of the so-called unicorn technology
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.